Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
35.00
-0.33 (-0.93%)
At close: Dec 5, 2025, 4:00 PM EST
35.05
+0.05 (0.14%)
After-hours: Dec 5, 2025, 5:01 PM EST
Travere Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3,132 | 1,516 | 676 | 1,350 | 1,900 | 1,391 | |
| Market Cap Growth | 130.72% | 124.43% | -49.94% | -28.99% | 36.59% | 128.10% | |
| Enterprise Value | 3,207 | 1,641 | 446 | 1,251 | 1,609 | 1,177 | |
| Last Close Price | 35.00 | 17.42 | 8.99 | 21.03 | 31.04 | 27.25 | |
| PS Ratio | 7.02 | 6.50 | 4.65 | 12.33 | 14.42 | 7.02 | |
| PB Ratio | 42.56 | 25.66 | 3.36 | 31.49 | 6.29 | 6.59 | |
| P/TBV Ratio | - | - | 7.01 | - | 12.37 | 24.37 | |
| EV/Sales Ratio | 7.36 | 7.04 | 3.07 | 11.43 | 12.21 | 5.93 | |
| Debt / Equity Ratio | 4.48 | 6.80 | 2.02 | 9.51 | 0.87 | 1.16 | |
| Asset Turnover | 0.84 | 0.34 | 0.20 | 0.15 | 0.19 | 0.33 | |
| Inventory Turnover | 37.05 | 28.86 | 36.81 | 39.16 | 27.48 | 20.15 | |
| Quick Ratio | 2.51 | 1.99 | 3.33 | 3.30 | 4.59 | 4.26 | |
| Current Ratio | 2.75 | 2.08 | 3.47 | 3.42 | 4.70 | 4.43 | |
| Return on Equity (ROE) | -410.78% | -246.75% | -308.90% | -192.18% | -84.66% | -78.37% | |
| Return on Assets (ROA) | -10.75% | -23.15% | -32.22% | -27.58% | -18.01% | -7.77% | |
| Return on Capital (ROIC) | -14.47% | -30.03% | -44.60% | -39.41% | -24.45% | -10.69% | |
| Return on Capital Employed (ROCE) | -22.20% | -65.10% | -61.70% | -60.30% | -30.60% | -14.60% | |
| Earnings Yield | -2.83% | -21.21% | -16.49% | -20.64% | -9.48% | -12.18% | |
| FCF Yield | -1.88% | -15.66% | -41.45% | -13.80% | -1.05% | -3.56% | |
| Buyback Yield / Dilution | -13.19% | -6.22% | -16.48% | -6.56% | -25.86% | -12.28% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.